1 completed. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow DF9001: new trials by email Literature Review of DF9001 trials Research Report on DF9001
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of DF9001 in Patients With Advanced Solid Tumors DF9001, KEYTRUDA® (pembrolizumab) - Solid Tumor, Adult | Phase 1 / Phase 2 | Completed | Dragonfly Therapeutics | 24 | 2022-11-15 | 2025-10-29 |
Carcinoma, Non-Small-Cell Lung (1) · Carcinoma, Renal Cell (1) · Squamous Cell Carcinoma of Head and Neck (1)
United States (1)